10x Care usdt,only buy and wait ...............................................................
We're seeing value health care ($XLV) show a lot of relative strength against other sectors as the dollar has been pushing. ($KRE) is often tied to growth when compared to it's bigger brother ($XLF) and eventhough financials do tend to benefit from rising rates, this has been much more of a hard landing and the financial rotation many expect may not come to pass,...
$ICLR may represent a buying opportunity on this pullback. Health care, specifically large cap health care like this one tend to do well in deflationary environments and with the Fed signaling 3 rate hikes in 2022 it may be an opportune time to get positioned.
This recent $PFE spinoff who went public via SPAC in 2020 could be a strong portfolio holding in the months and years to come. Experienced leadership taking on the unique challenge of solving a lot of the mental health issues that could very well be leading to the tight labor markets we've witnessed recently.
ZNTL broke 80 again today and is displaying a strong monthly momentum chart. IBB regaining 160 hopefully will signal at least a moderate health care push that could push ZNTL into the 90s and beyond. Good luck traders!
TP 1 : > 500 TP 2 : > 510 SL : < 432 Risk In Your Hand Press Like & Follow if u like my content
Investors should continue to watch Merck and how it plays out here at the 80 level as their COVID drug treatment is pending approval. I believe the market is absolutely sleeping on the significance of this drug and the kind of impact it will have. A treatment is an absolute game changer provided the politics of COVID do not disrupt innovation, transparency and...
ALGN has been outpacing pretty much every major index on a monthly / weekly time frame. I expect this momentum to continue over the long run. Company has a significant economic moat and this could be turn into 1000+ quicker than you might think
XBI (Nasdaq biotech ETF) losing more key levels today and with other health care names already pretty saturated to the upside, could that mean CLOV isn't done falling?
Promising biotech setup here, had a nice break of 70 recently and may be looking to go higher. Potentially risky if XBI rolls over but strong momentum here nonetheless. Good luck traders!
WATCHING $CARE for ENTRY TARGET @ 12.69 I’m practicing to nail my entries even better… IF target hits I will look at this again and possibly take a position. I’m adding this to my watchlist for next week but THIS ONE is getting close. Look to the right. Entry target in grey. Sell target in green. Double position target in red. That’s it.
My advisor Marketmiracle gave an input signal for the stock ALIGN TECHNOLOGY $ALGN at a price of 588.09 usd with a target of 634.1391 with a possible profit of 7.83% According to the chart the stock seems to actually want to continue to rise despite the laggera situation of over-bought, the rest less than a month ago has delivered excellent results with a...
Happy New Year & Happy Valentine 2021! May this new year be filled with love and cheer!
Interesting setup here in ONEM. Creating the handle here with a nice risk reward skew. Could be worth a look
I really like UNH in this space. Health insurance names in general seem to want to push higher. Nice inverse head and shoulders here on the daily with what could be a market bottom. Starting to pick up a bit of biotech as well to compliment
A little bit about CARE: Carter Bank & Trust provides a range of retail and commercial banking products and services in Virginia and North Carolina. The company also offers loans, such as secured and unsecured commercial loans; secured and unsecured consumer loans for financing automobiles, home improvements, education, and personal investments; real estate...
Care ratings has tested price 440 couple of times and have been facing selling pressure.
Service Corp. International (SCI) is the obvious conservative (market cap $6.9 billion) candidate while Carriage Services ($274 million) is the more prospective growth story in the US. A smallish Canadian company (market cap $574 million) has experience very rapid revenue growth of late but is a higher beta stock. All pay dividends ranging around 2%.